drugset / Trial / NCT04360135

Preemptive Acetaminophen for Postoperative Pain Control Following Minimally Invasive Hysterectomy

NCT04360135 ↗

Phase 2/3 Withdrawn Montefiore Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is investigating whether administration of acetaminophen the day before surgery improves post operative pain following minimally invasive hysterectomy. Patients will receive either acetaminophen or placebo to take twice per day the day prior to their scheduled surgery. The morning of surgery all participants will receive oral acetaminophen at least 30 minutes prior to surgery. The investigators will examine whether there is a difference in post operative pain between the two groups.

Timeline

Start
2020-05-06
Primary completion
2021-03-08
Completion
2021-03-08

Outcome

Outcome not reported

Stopped (Enrollment): “The study was closed on 3/8/2021 as per final progress report issued by the IRB on 3/12/2021. No subjects were enrolled in the study following approval. Status changed to "Withdrawn (No Participants Enrolled)" accordingly.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 975 mg Oral

Indications

No indication recorded.